Insmed (INSM) Selling, General & Administrative (2010 - 2026)
Insmed (INSM) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
SG&A (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
17.02 Mn |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
1.32 Mn |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
-37.00 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
2.17 Mn |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
-1.52 Mn |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
217,225.00 |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
493.70 Mn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
-7.36 Mn |
| 10 |
Insmed |
21.32 Bn |
20.09 Bn |
258.54 Mn |
247.26 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
247.26 Mn |
| Dec 31, 2025 |
212.48 Mn |
| Sep 30, 2025 |
186.38 Mn |
| Jun 30, 2025 |
154.76 Mn |
| Mar 31, 2025 |
147.55 Mn |
| Dec 31, 2024 |
142.52 Mn |
| Sep 30, 2024 |
118.93 Mn |
| Jun 30, 2024 |
106.57 Mn |
| Mar 31, 2024 |
93.10 Mn |
| Dec 31, 2023 |
89.53 Mn |
| Sep 30, 2023 |
90.63 Mn |
| Jun 30, 2023 |
84.43 Mn |
| Mar 31, 2023 |
79.91 Mn |
| Dec 31, 2022 |
73.48 Mn |
| Sep 30, 2022 |
75.58 Mn |
| Jun 30, 2022 |
59.97 Mn |
| Mar 31, 2022 |
56.75 Mn |
| Dec 31, 2021 |
65.27 Mn |
| Sep 30, 2021 |
60.28 Mn |
| Jun 30, 2021 |
57.18 Mn |
